Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug 28;55(9):544.
doi: 10.3390/medicina55090544.

A Nutraceutical Approach to Menopausal Complaints

Affiliations
Review

A Nutraceutical Approach to Menopausal Complaints

Pasquale De Franciscis et al. Medicina (Kaunas). .

Abstract

The menopausal transition, or perimenopause, is characterized by menstrual irregularities, vasomotor symptoms, sleep disturbances, mood symptoms, and urogenital tract atrophy. These changes can also affect the quality of life and one's self-esteem. Hormone replacement therapy (HRT) is considered the best option to achieve therapeutic relief of different menopausal symptoms but is usually restricted to moderate or severe symptoms. Moreover, many women refuse HRT for a variety of reasons concerning the fear of cancer and other adverse effects. According to these considerations, new topics are emerging: Dissatisfaction with drug costs and conventional healthcare, desire for personalized medicines, and the public perception that "natural is good". In this context, nonhormonal therapies are mostly evolving, and it is not unusual that women often request a "natural" approach for their symptoms. The aim of this study is to investigate nonhormonal therapies that have been identified to reduce the menopausal symptoms.

Keywords: Agnus castus; isoflavones; menopausal symptoms; menopause; natural approach; nutraceuticals; sleep disturbances; supplementation; vasomotor symptoms.

PubMed Disclaimer

Conflict of interest statement

Authors declare no conflict of interests, commercial or financial in writing this article.

Figures

Figure 1
Figure 1
Nutraceutical and the choice of menopausal therapy. Nonhormonal therapies represent a developing option that is characterized by medical information and discussion with the patient. The customization of the therapy is a fundamental point and depends on many factors, clinical and not, such as previous therapies, risk factors, and type of symptoms. Points of strength in nutraceutical choice are: They are user-friendly, are useful as a first approach to menopausal complaints, can be used together with drugs, and are useful if HRT is refused or contraindicated.

References

    1. Soules M.R., Sherman S., Parrott E., Rebar R., Santoro N., Utian W., Woods N. Executive summary: Stages of reproductive aging workshop (STRAW) Fertil. Steril. 2001;76:874–878. doi: 10.1016/S0015-0282(01)02909-0. - DOI - PubMed
    1. Bajwa S., Singh A., Bajwa S.J. Nutritional facts and menopausal symptomatology: The role of nutraceuticals. J. Med. Nutr. Nutraceuticals. 2012;1:42–49. doi: 10.4103/2278-019X.94633. - DOI
    1. Ainsworth A.J., Baumgarten S.C., Bakkum-Gamez J.N., Vachon C.M., Weaver A.L., Laughlin-Tommaso S.K. Tubal Ligation and Age at Natural Menopause. Obstet. Gynecol. 2019;133:1247–1254. doi: 10.1097/AOG.0000000000003266. - DOI - PMC - PubMed
    1. Li R.-L., Shen X.-L., Xu F., Shui X.-J., Chen Y.-M., Wang W.-H., Zheng J.-Y. Evaluation of ovarian function using three dimensional ultrasound in perimenopausal women. Gynecol. Endocrinol. 2019 doi: 10.1080/09513590.2019.1625879. - DOI - PubMed
    1. De Franciscis P., Cobellis L., Fornaro F., Sepe E., Torella M., Colacurci N. Low-dose hormone therapy in the perimenopause. Int. J. Gynecol. Obstet. 2007;98:138–142. doi: 10.1016/j.ijgo.2007.04.008. - DOI - PubMed

MeSH terms